Amgen, Inc. (AMGN)
347.80
-2.12
(-0.61%)
USD |
NASDAQ |
Mar 20, 16:00
349.89
+2.09
(+0.60%)
After-Hours: 20:00
Amgen Research and Development Expense (Annual) : 6.974B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Biogen, Inc. | 1.481B |
| Gilead Sciences, Inc. | 5.688B |
| Johnson & Johnson | 14.83B |
| Eli Lilly & Co. | 13.34B |
| Regeneron Pharmaceuticals, Inc. | 5.306B |